Display options
Share it on

Clin Ophthalmol. 2010 Feb 02;4:11-20.

Antiviral selection in the management of acute retinal necrosis.

Clinical ophthalmology (Auckland, N.Z.)

Patrick M K Tam, Claire Y Hooper, Susan Lightman

Affiliations

  1. Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, N.T., Hong Kong, People's Republic of China.

PMID: 20169044 PMCID: PMC2819764

Abstract

There is no consensus on the optimal antiviral regimen in the management of acute retinal necrosis, a disease caused by herpetic viruses with devastating consequences for the eye. The current gold standard is based on retrospective case series. Because the incidence of disease is low, few well-designed, randomized trials have evaluated treatment dosage and duration. Newer oral antiviral agents are emerging as alternatives to high-dose intravenous acyclovir, avoiding the need for inpatient intravenous treatment. Drug resistance is uncommon but may also be difficult to identify. Antiviral drugs have few side effects, but special attention needs to be paid to patients who have underlying renal disease, are pregnant or are immunocompromised.

Keywords: acute retinal necrosis; acyclovir; herpes; retinitis

References

  1. Semin Ophthalmol. 2008 Jul-Aug;23(4):285-90 - PubMed
  2. Am J Kidney Dis. 2005 May;45(5):804-17 - PubMed
  3. Br J Ophthalmol. 1978 Sep;62(9):581-90 - PubMed
  4. Drugs. 1996 Nov;52(5):754-72 - PubMed
  5. Retina. 1987 Spring;7(1):9-13 - PubMed
  6. Jpn J Ophthalmol. 2009 Sep;53(5):486-9 - PubMed
  7. Am J Ophthalmol. 2009 Jul;148(1):38-42.e1 - PubMed
  8. J Clin Pharmacol. 1999 Aug;39(8):800-4 - PubMed
  9. Br J Ophthalmol. 1984 Mar;68(3):192-5 - PubMed
  10. Antimicrob Agents Chemother. 1979 May;15(5):642-5 - PubMed
  11. Am J Ophthalmol. 2008 Apr;145(4):682-6 - PubMed
  12. Retina. 1986 Spring-Summer;6(2):85-94 - PubMed
  13. Antimicrob Agents Chemother. 2003 Aug;47(8):2438-41 - PubMed
  14. Indian J Pediatr. 2006 Apr;73(4):313-21 - PubMed
  15. Br J Ophthalmol. 2007 Nov;91(11):1452-5 - PubMed
  16. Am J Med. 1982 Jul 20;73(1A):176-81 - PubMed
  17. Br J Ophthalmol. 1986 Feb;70(2):138-40 - PubMed
  18. Retina. 2002 Jun;22(3):352-4 - PubMed
  19. Am J Ophthalmol. 1997 Feb;123(2):255-7 - PubMed
  20. J Clin Virol. 2003 Jan;26(1):29-37 - PubMed
  21. Antimicrob Agents Chemother. 1996 Jan;40(1):80-5 - PubMed
  22. Neuropediatrics. 2004 Dec;35(6):371-6 - PubMed
  23. J Antimicrob Chemother. 1983 Sep;12 Suppl B:29-37 - PubMed
  24. Arch Ophthalmol. 1984 Dec;102(12):1750 - PubMed
  25. Antimicrob Agents Chemother. 1998 Jul;42(7):1555-62 - PubMed
  26. Am J Med. 1988 Jun;84(6):1067-71 - PubMed
  27. Int Ophthalmol. 2009 Jun;29(3):199-201 - PubMed
  28. N Engl J Med. 1991 Oct 17;325(16):1178-9 - PubMed
  29. Transplantation. 2007 Mar 27;83(6):694-9 - PubMed
  30. Am J Ophthalmol. 1994 May 15;117(5):663-7 - PubMed
  31. Drugs. 1996 Jul;52(1):17-32 - PubMed
  32. J Infect Dis. 2002 Oct 15;186 Suppl 1:S40-6 - PubMed
  33. N Engl J Med. 2002 Apr 11;346(15):1119-26 - PubMed
  34. Am J Ophthalmol. 1991 Sep 15;112(3):250-5 - PubMed
  35. AIDS. 1996 Jan;10(1):55-60 - PubMed
  36. Birth Defects Res A Clin Mol Teratol. 2004 Apr;70(4):201-7 - PubMed
  37. Antimicrob Agents Chemother. 1994 Jul;38(7):1534-40 - PubMed
  38. Ophthalmology. 2006 Dec;113(12):2259-61 - PubMed
  39. Antimicrob Agents Chemother. 1980 Sep;18(3):443-7 - PubMed
  40. N Engl J Med. 1986 Jan 16;314(3):144-9 - PubMed
  41. Ophthalmology. 2008 Jun;115(6):1104-5; author reply 1105-6 - PubMed
  42. Ophthalmology. 1989 Jun;96(6):875-8 - PubMed
  43. Int Ophthalmol. 2009 Apr;29(2):85-90 - PubMed
  44. J Med Virol. 1992 Jan;36(1):1-12 - PubMed
  45. Antimicrob Agents Chemother. 1995 Dec;39(12):2759-64 - PubMed
  46. Clin Pharmacol Ther. 1993 Dec;54(6):595-605 - PubMed
  47. Ocul Immunol Inflamm. 2003 Jun;11(2):141-4 - PubMed
  48. Ophthalmology. 2008 Feb;115(2):306-11 - PubMed
  49. Antimicrob Agents Chemother. 1998 Apr;42(4):868-72 - PubMed
  50. Ophthalmic Surg. 1987 Feb;18(2):111-4 - PubMed
  51. J Antimicrob Chemother. 2001 Jun;47(6):855-61 - PubMed
  52. Retina. 1993;13(3):208-13 - PubMed
  53. Ophthalmology. 1986 May;93(5):559-69 - PubMed
  54. Ophthalmology. 1986 Mar;93(3):296-300 - PubMed
  55. Antimicrob Agents Chemother. 1994 Oct;38(10):2454-7 - PubMed
  56. Am J Ophthalmol. 2004 May;137(5):872-9 - PubMed
  57. Am J Ophthalmol. 1994 Feb 15;117(2):201-10 - PubMed
  58. J Antimicrob Chemother. 1983 Sep;12 Suppl B:19-27 - PubMed
  59. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716-20 - PubMed
  60. Rev Chilena Infectol. 2007 Aug;24(4):323-6 - PubMed
  61. Ophthalmology. 2009 Oct;116(10):1971-5.e2 - PubMed
  62. Medicine (Baltimore). 1997 Sep;76(5):369-80 - PubMed
  63. Eye (Lond). 2004 May;18(5):544-5 - PubMed
  64. Antimicrob Agents Chemother. 1996 Apr;40(4):846-51 - PubMed
  65. Am J Kidney Dis. 1992 Dec;20(6):647-9 - PubMed
  66. Ophthalmology. 2007 Feb;114(2):307-12 - PubMed
  67. Ann Intern Med. 1990 Mar 15;112(6):416-22 - PubMed
  68. Am J Ophthalmol. 1999 Jan;127(1):93-5 - PubMed
  69. Retina. 1982;2(3):145-51 - PubMed
  70. Clin Pharmacokinet. 1999 Aug;37(2):167-76 - PubMed
  71. J Gen Virol. 1983 Mar;64 Pt 3:523-32 - PubMed
  72. Ocul Immunol Inflamm. 2007 Sep-Oct;15(5):395-8 - PubMed
  73. Clin Exp Ophthalmol. 2009 Jul;37(5):473-7 - PubMed
  74. Ocul Immunol Inflamm. 2007 Nov-Dec;15(6):425-7 - PubMed
  75. N Engl J Med. 1999 May 13;340(19):1462-70 - PubMed
  76. Neurology. 2008 Oct 14;71(16):1268-74 - PubMed
  77. Drugs. 1995 Aug;50(2):396-415 - PubMed
  78. Nephron. 1990;56(4):436-8 - PubMed
  79. Ophthalmology. 1982 Dec;89(12):1317-25 - PubMed

Publication Types